EA200000860A1 - Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты) - Google Patents

Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты)

Info

Publication number
EA200000860A1
EA200000860A1 EA200000860A EA200000860A EA200000860A1 EA 200000860 A1 EA200000860 A1 EA 200000860A1 EA 200000860 A EA200000860 A EA 200000860A EA 200000860 A EA200000860 A EA 200000860A EA 200000860 A1 EA200000860 A1 EA 200000860A1
Authority
EA
Eurasian Patent Office
Prior art keywords
variants
options
bacterial infection
polynucleotides
polypeptide
Prior art date
Application number
EA200000860A
Other languages
English (en)
Russian (ru)
Inventor
Мартин Бойе
Бернар Р. Бродор
Дени Мартин
Клеман Риу
Хосе Хамель
Изабель Шарльбуа
Original Assignee
Байокем Фармэ Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байокем Фармэ Инк. filed Critical Байокем Фармэ Инк.
Publication of EA200000860A1 publication Critical patent/EA200000860A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EA200000860A 1998-02-20 1999-02-17 Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты) EA200000860A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7542598P 1998-02-20 1998-02-20
PCT/CA1999/000114 WO1999042588A2 (en) 1998-02-20 1999-02-17 Group b streptococcus antigens

Publications (1)

Publication Number Publication Date
EA200000860A1 true EA200000860A1 (ru) 2001-10-22

Family

ID=22125658

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000860A EA200000860A1 (ru) 1998-02-20 1999-02-17 Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты)

Country Status (22)

Country Link
US (4) US20030031682A1 (https=)
EP (3) EP1054971B1 (https=)
JP (2) JP4637350B2 (https=)
KR (1) KR100771148B1 (https=)
CN (2) CN1944652A (https=)
AP (1) AP2000001886A0 (https=)
AT (1) ATE347600T1 (https=)
AU (1) AU2505999A (https=)
CA (1) CA2321106C (https=)
CZ (1) CZ301056B6 (https=)
DE (1) DE69934299T2 (https=)
EA (1) EA200000860A1 (https=)
ES (2) ES2540281T3 (https=)
HU (1) HU228497B1 (https=)
ID (1) ID27482A (https=)
IL (3) IL137921A0 (https=)
NO (2) NO330491B1 (https=)
NZ (1) NZ529854A (https=)
OA (1) OA11686A (https=)
TR (1) TR200002437T2 (https=)
WO (1) WO1999042588A2 (https=)
ZA (1) ZA991325B (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2321106C (en) 1998-02-20 2013-07-23 Biochem Pharma Inc. Group b streptococcus antigens
US7098182B2 (en) 1998-07-27 2006-08-29 Microbial Technics Limited Nucleic acids and proteins from group B streptococcus
WO2000006736A2 (en) * 1998-07-27 2000-02-10 Microbial Technics Limited Nucleic acids and proteins from group b streptococcus
GB0105922D0 (en) * 2001-03-09 2001-04-25 Microscience Ltd Genes and proteins, and their use
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
CN101066447A (zh) 1998-12-22 2007-11-07 微科学有限公司 基因和蛋白质,及它们的用途
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
US6833356B1 (en) 1999-08-25 2004-12-21 Medimmune, Inc. Pneumococcal protein homologs and fragments for vaccines
AU7076100A (en) * 1999-08-25 2001-03-19 Med Immune, Inc. Homologs of a pneumococcal protein and fragments for vaccines
US6866855B2 (en) 2000-06-12 2005-03-15 University Of Saskatchewan Immunization of dairy cattle with GapC protein against Streptococcus infection
US6833134B2 (en) 2000-06-12 2004-12-21 University Of Saskacthewan Immunization of dairy cattle with GapC protein against Streptococcus infection
DK1294771T3 (da) 2000-06-12 2008-12-15 Univ Saskatchewan Kimært GapC-protein fra Streptococcus og anvendelse deraf til vaccinering og diagnosticering
EP1734050A3 (en) * 2000-06-12 2012-12-05 University Of Saskatchewan Immunization of dairy cattle with GapC protein against streptococcus infection
ES2273861T3 (es) * 2000-06-12 2007-05-16 University Of Saskatchewan Inmunizacion de ganado vacuno lechero con proteina gapc frente a infecciones por streptococcus.
JP4102186B2 (ja) 2000-10-13 2008-06-18 アイディー バイオメディカル コーポレイション グループｂストレプトコッカスのｂｖｈ−ａ２及びｂｖｈ−ａ３抗原
CA2881568C (en) 2000-10-27 2019-09-24 Novartis Vaccines And Diagnostics, Inc. Nucleic acids and proteins from streptococcus groups a & b
AU2002216863B8 (en) * 2000-12-21 2008-03-20 Id Biomedical Corporation Streptococcus pyogenes antigens and corresponding DNA fragments
FR2824074A1 (fr) * 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
ES2381967T3 (es) * 2002-02-11 2012-06-04 Id Biomedical Corporation Antígeno de streptococcus del grupo B
GB0210128D0 (en) * 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
ES2505695T3 (es) 2003-07-31 2014-10-10 Novartis Vaccines And Diagnostics, Inc. Composiciones inmunógenas para Streptococcus pyogenes
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
JP2008508320A (ja) 2004-07-29 2008-03-21 カイロン コーポレイション Ｓｔｒｅｐｔｏｃｏｃｃｕｓａｇａｌａｃｔｉａｅのようなグラム陽性細菌に対する免疫原性組成物
US7838010B2 (en) 2004-10-08 2010-11-23 Novartis Vaccines And Diagnostics S.R.L. Immunogenic and therapeutic compositions for Streptococcus pyogenes
EP1845944A4 (en) * 2005-02-08 2011-07-27 Id Biomedical Corp Of Quebec C O B As Glaxosmithkline Biolog North America PHARMACEUTICAL COMPOSITIONS
GB0605247D0 (en) * 2006-03-15 2006-04-26 Chiron Srl Compositions and methods for immunisation
KR101621837B1 (ko) 2007-09-12 2016-05-17 노파르티스 아게 Ｇａｓ57 돌연변이 항원 및 ｇａｓ57 항체
EP2537857B1 (en) 2007-12-21 2017-01-18 GlaxoSmithKline Biologicals SA Mutant forms of streptolysin O
CN102304185A (zh) * 2011-09-02 2012-01-04 黑龙江八一农垦大学 预防奶牛乳房炎的融合蛋白sip-trap及制备方法和应用
EP2949340A1 (en) * 2014-05-30 2015-12-02 IDT Biologika GmbH Vaccine composition against Streptococcus suis infection
CN115057944B (zh) * 2022-06-24 2025-06-24 南京农业大学 一种针对所有gbs血清型的多表位亚单位疫苗

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431739A (en) 1979-11-05 1984-02-14 Genentech, Inc. Transformant bacterial culture capable of expressing heterologous protein
US4425437A (en) 1979-11-05 1984-01-10 Genentech, Inc. Microbial polypeptide expression vehicle
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US5472696A (en) * 1988-02-26 1995-12-05 Univ. Of Florida Research Foundation, Inc. Antigen of group B streptococci
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
US5679768A (en) * 1991-02-15 1997-10-21 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
US5225331A (en) * 1991-04-25 1993-07-06 National Research Council Of Canada Immunoassay for detecting group b streptococcus
HU217582B (hu) * 1993-03-19 2000-02-28 Gunnar Lindahl Streptococcus B csoportba tartozó törzsek elleni immunitást biztosító, Rib fehérjenevű felületi protein, eljárás a protein tisztítására, reagenskészlet és gyógyszerkészítmény
US5595740A (en) * 1994-05-16 1997-01-21 University Of Florida Cloning of non-IgA FC binding forms of the group B streptococcal beta antigens
TW448184B (en) * 1994-11-01 2001-08-01 Kirin Brewery Peptide sequence that forms muscous glycoprotein chain and technique for producing thereof
JP4469026B2 (ja) * 1996-10-31 2010-05-26 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド Ｓｔｒｅｐｔｏｃｏｃｃｕｓ ｐｎｅｕｍｏｎｉａｅの抗原およびワクチン
CA2321106C (en) * 1998-02-20 2013-07-23 Biochem Pharma Inc. Group b streptococcus antigens
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
WO2000006736A2 (en) 1998-07-27 2000-02-10 Microbial Technics Limited Nucleic acids and proteins from group b streptococcus
EP1140157B1 (en) 1998-12-21 2009-02-18 MedImmune, Inc. Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
KR100802198B1 (ko) 1998-12-23 2008-02-11 샤이어 바이오켐 인코포레이티드 신규한 스트렙토코커스 항원
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
GB9921125D0 (en) 1999-09-07 1999-11-10 Microbial Technics Limited Proteins
ES2381967T3 (es) * 2002-02-11 2012-06-04 Id Biomedical Corporation Antígeno de streptococcus del grupo B

Also Published As

Publication number Publication date
CN1944652A (zh) 2007-04-11
ID27482A (id) 2001-04-12
NO20101682L (no) 2000-10-19
NO330491B1 (no) 2011-05-02
DE69934299T2 (de) 2007-07-05
JP4637350B2 (ja) 2011-02-23
EP1054971A2 (en) 2000-11-29
IL190018A (en) 2011-07-31
IL190018A0 (en) 2008-08-07
CA2321106A1 (en) 1999-08-26
WO1999042588A3 (en) 2000-03-23
KR20010034518A (ko) 2001-04-25
AP2000001886A0 (en) 2000-09-30
EP2280072B1 (en) 2015-03-25
CN1297482A (zh) 2001-05-30
IL137921A (en) 2008-06-05
WO1999042588A2 (en) 1999-08-26
HU228497B1 (en) 2013-03-28
US20110182923A1 (en) 2011-07-28
CN1268745C (zh) 2006-08-09
EP2280072A3 (en) 2012-06-06
TR200002437T2 (tr) 2000-11-21
DE69934299D1 (de) 2007-01-18
US20030031682A1 (en) 2003-02-13
NO20004161D0 (no) 2000-08-18
IL137921A0 (en) 2001-10-31
HUP0102304A1 (hu) 2001-10-28
JP2009242403A (ja) 2009-10-22
OA11686A (en) 2005-01-12
ES2278436T3 (es) 2007-08-01
EP1054971B1 (en) 2006-12-06
ES2540281T3 (es) 2015-07-09
US8580262B2 (en) 2013-11-12
KR100771148B1 (ko) 2007-10-29
NO20004161L (no) 2000-10-19
US8226953B2 (en) 2012-07-24
EP2280072A2 (en) 2011-02-02
CA2321106C (en) 2013-07-23
HUP0102304A3 (en) 2008-03-28
AU2505999A (en) 1999-09-06
US7914794B2 (en) 2011-03-29
NZ529854A (en) 2005-08-26
ATE347600T1 (de) 2006-12-15
JP2002507396A (ja) 2002-03-12
CZ301056B6 (cs) 2009-10-29
EP1757697A2 (en) 2007-02-28
EP1757697A3 (en) 2007-05-30
CZ20003054A3 (cs) 2001-03-14
US20130095498A1 (en) 2013-04-18
US20030228323A1 (en) 2003-12-11
ZA991325B (en) 1999-08-20

Similar Documents

Publication Publication Date Title
EA200000860A1 (ru) Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты)
EA200201280A1 (ru) Стрептококковые антигены
EA200100565A1 (ru) Новые стрептококковые антигены
EE200200709A (et) Liitvalku sisaldava kompositsiooni ning seda liitvalku ja liitpolüpeptiidi kodeeriva nukleiinhappe kasutamine
DK0950068T3 (da) Kollagen-bindende proteinsammensatninger og fremgangsmade til anvendelse
ZA965482B (en) Novel antigen.
ATE430200T1 (de) Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus
NO329875B1 (no) Isolert DNA-sekvens som koder for svinereproduktive- og respiratoriske syndromvirus (PRRSV), en sammensetning omfattende polypeptidene kodet av denne, en sammensetning for indusering av antistoffer mot PRRSV, anvendelse av sammensetning for fremstilling av vaksine og fremgangsmate for a skille PRRSV-stamme ISU-55 fra andre PRRSV-stammer.
FI895050A0 (fi) Diagnostiska preparat och vaccin foer mykobakterier i folkhaelso-, medicinsk och veterinaermedicinsk praxis.
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
SG144692A1 (en) Antigenic proteins of shrimp white spot syndrome virus and uses thereof
DK0909323T3 (da) Helicobacter pylori-bakterioferritin
DE3650011D1 (de) EXPRESSION UND DIAGNOSE MIT gag-KODIERTEN PEPTIDEN, DIE MIT ANTIKÖRPERN GEGEN LAV IMMUNOLOGISCH REAKTIV SIND.
ATE159170T1 (de) Impfstoffe und diagnosetest für haemophilus influenzae
DE3751727D1 (de) Polypeptide zur verwendung bei der diagnose von mycoplasmainfektionen bei schweinen, sowie rekombinant-dns-verfahren zur herstellung derselben
IE870507L (en) Bovine virus diarrhea and hog cholera vaccines
ATE124420T1 (de) Impfstoffe und testsätze für haemophilus influenzae.
DE60035485D1 (de) IDENTIFIZIERUNG VON SPEZIFISCHEN DIFFERENZIELL EXPRIMIERTEN ANTIGENEN AUS MYCOBACTERIUM UND MEDIZINISCHE VERWENDUNG DER MYCOBAKTERIUMPROTEINE Rv0068 UND Rv3407
WO1995020658A3 (en) Diagnosis and treatment of infections due to streptococci and enterococci
CA2284110A1 (en) An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
RU2000131225A (ru) Белки moraxella catarrhalis
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli
NO923828L (no) Polypeptider, nyttige til diagnose av og behandling mot mycoplasma-infeksjoner hos dyr
EP1950302A3 (en) Streptococcus antigens